A Validation Study of Patient Interview Data and Pharmacy Records for Antihypertensive, Statin, and Antidepressant Medication Use among Older Women

American Journal of Epidemiology

Volumn 159, Issue 3, 2004, Pages 308-317

  Boudreau, Denise M ^a,b,d   Daling, Janet R ^b,c   Malone, Kathleen E ^b,c   Gardner, Jacqueline S ^b   Blough, David K ^b   Heckbert, Susan R ^a,b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Antidepressive agents; Antihypertensive agents; Hydroxymethylglutaryl CoA reductase inhibitors; Interviews; Validation studies publication type ; Women

Indexed keywords

AMFEBUTAMONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

DRUG PRESCRIBING;

AGED; ARTICLE; CASE CONTROL STUDY; CHEMOSENSITIVITY; CONFIDENCE INTERVAL; DEPRESSION; DRUG MONITORING; DRUG SPECIFICITY; DRUG USE; ELDERLY CARE; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; RECALL; SELF REPORT; STATISTICAL ANALYSIS; UNITED STATES; VALIDATION PROCESS;

AGED; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; DATA COLLECTION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEDICAL RECORDS; MENTAL RECALL; PREVALENCE; REPRODUCIBILITY OF RESULTS; WASHINGTON;

EID: 0942279636     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh038     Document Type: Article

References (35)

1. Armstrong BK, White E, Saracci R. Principles of exposure measurement in epidemiology. Vol 21. Oxford, United Kingdom: Oxford University Press, 2000.
2. Skegg DCG. Potential for bias in case-control studies of oral contraceptives and breast cancer. Am J Epidemiol 1988;127:205-15.
3. Norell SE, Boethius G, Persson I. Oral contraceptive use: interview data versus pharmacy records. Int J Epidemiol 1998;27:1033-7.
4. Nischan P, Ebeling K, Thomas D, et al. Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol 1993;138:697-703.
5. Stolley PD, Tonascia JA, Sartwell PE, et al. Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol 1978;107:226-35.
6. Coulter A, Vessey M, McPherson K, et al. The ability of women to recall their oral contraceptive histories. Contraception 1986;33:127-37.
7. Rosenberg MJ, Layde PM, Ory HW, et al. Agreement between women's histories of oral contraceptive use and physician records. Int J Epidemiol 1983;12:84-7.
8. Adam SA, Sheaves J, Wright NH, et al. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 1981;44:45-50.
9. Horowitz RI, Feinstein AR, Stremlau JR. Alternative data sources and discrepant results in case-control studies of estrogens and endometrial cancer. Am J Epidemiol 1980;1111:389-94.
10. Goodman MT, Nomura AM, Wilkens LR, et al. Agreement between interview information and physician records on the history of menopausal estrogen use. Am J Epidemiol 1990;131:815-25.
11. Spengler RF, Clark EA, Woolever CA, et al. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases. Am J Epidemiol 1981;114:497-506.
12. Paganini-Hill A, Ross R. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982;116:114-22.
13. Harlow S, Linet M. Agreement between questionnaire data and medical records. Am J Epidemiol 1989;142:1103-12.
14. Persson I, Bergkvist L, Adami HO. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol. 1987;16:2227-8.
15. West SL, Savitz DA, Koch G, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995;142:1103-12.
16. Cotterchio M, Kreiger N, Darlington G, et al. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol 1999;9:283-9.
17. Psaty BM, Lee M, Savage PJ, et al. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 1992;45:683-92.
18. Sjahid SI, Van der Linden PD, Stricker BH. Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. Br J Clin Pharmacol 1998;45:591-5.
19. Kehoe R, Wu SY, Leske MC, et al. Comparing self-reported and physician-reported medical history. Am J Epidemiol 1994;139:813-18.
20. West SL, Strom BL, Freundlich B, et al. Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol 1994;47:165-71.
21. West SL, Strom BL, Poole C. Validity of pharmacoepidemiology drug and diagnosis data. In: Strom B, ed. Pharmacoepidemiology. 2nd ed. Chichester, United Kingdom: John Wiley & Sons, Inc, 2000:661-705.
22. Christensen DB, Williams B, Goldberg HI, et al. Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy. Ann Pharmacother 1994;28:99-104.
23. Heerdink LR, Leufkens HC, Koppedraaijer C, et al. Information on drug use in the elderly: a comparison of pharmacy, general practitioner, and patient data. Pharm World Sci 1995;17:20-4.
24. Apodaca R, Judkins D, Lo A, et al. Sampling from CMS lists. In: Proceedings of the section on survey research methods. Alexandria, VA: American Statistical Association, 1992:250-5.
25. Saunders KW, Stergachis A, VonKorff M. Group Health Cooperative of Puget Sound. In: Strom B, ed. Pharmacoepidemiology. 2nd ed. Chichester, United Kingdom: John Wiley & Sons, Inc, 1994:171-85.
26. Sewester CS, Dombek CE, Olin BR, et al, eds. Drug facts and comparisons 2001. St Louis, MO: Facts & Comparisons, 2001.
27. Rothman KJ, Greenland S. Modem epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1998.
28. Altman DG, Bryant TN, Gardner MJ. Statistics with confidence. 2nd ed. Bristol, United Kingdom: British Medical Journal Books, 2000.
29. Fleiss J, Cohen J. The equivalence of weighed kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 1973;33:613-19.
30. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000;19:1141-64.
31. Morton AP, Dobson AJ. Assessing agreement. Med J Aust 1989;150:384-7.
32. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York, NY: John Wiley & Sons, Inc, 1981.
33. Maclure M, Willett WC. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol 1987;126:161-9.
34. Lantz CA, Nebenzahl E. Behavior and interpretation of the kappa statistic: resolution of the two paradoxes. J Clin Epidemiol 1996;49:431-4.
35. Copeland KT, Checkoway H, McMichael AJ, et al. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-94.